Literature DB >> 12758247

Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis.

Tetsuya Aoki1, Yasushi Nagata, Takashi Mizowaki, Masaki Kokubo, Yoshiharu Negoro, Kenji Takayama, Michihide Mitsumori, Keisuke Sasai, Masahiro Hiraoka.   

Abstract

PURPOSE: This study was performed to evaluate the efficacy and safety of dynamic arc conformal radiotherapy, a simple intensity modulated radiation therapy (IMRT), for the treatment of paraaortic lymph node metastases.
MATERIALS AND METHODS: Twenty-nine patients with paraaortic lymph node metastases were enrolled in this study. The total planned dose was 55-60 Gy. A computed tomography (CT) simulator was used in the treatment planning.
RESULTS: The total radiation dose delivered was 50-63.4 Gy (median 60 Gy). Sixteen of 29 patients showed local tumor shrinkage on CT, and the 2 year in-field recurrence free survival rate was 58%. Acute Grade 1 and Grade 2 gastrointestinal disorders occurred in 31% and 17%, respectively, and acute Grade 2 liver dysfunction occurred in 7%. As a late complication, Grade 1 and Grade 2 liver dysfunction occurred in six patients (21%) and five patients (17%), respectively. There was no renal dysfunction or myelopathy detected.
CONCLUSION: Dynamic arc conformal radiotherapy, a simple IMRT, is a safe and effective treatment method for paraaortic lymph node metastasis.

Entities:  

Mesh:

Year:  2003        PMID: 12758247     DOI: 10.1016/s0167-8140(02)00388-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  1 in total

1.  Feasibility evaluation of a new irradiation technique: three-dimensional unicursal irradiation with the Vero4DRT (MHI-TM2000).

Authors:  Takashi Mizowaki; Kenji Takayama; Kazuo Nagano; Yuki Miyabe; Yukinori Matsuo; Shuji Kaneko; Masaki Kokubo; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-08-24       Impact factor: 2.724

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.